You are viewing: Asia Pacific Theranostics Market analysis
Part of: Theranostics Market (Global)

The Asia Pacific Theranostics Market was valued at $565.1 Million in 2023 and projected to reach to $1077.5 Million by 2028, representing a compound annual growth rate of 13.8%. The Asia Pacific theranostics market is poised for substantial growth through 2028, driven by expanding healthcare infrastructure and rising chronic disease incidence across the region.

Asia Pacific Theranostics Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Theranostics Market Trends and Insights

  • Asia Pacific's theranostics sector is driven by rising healthcare investments, increasing prevalence of chronic diseases, and growing adoption of precision medicine across the region.
  • The market in Asia Pacific benefits from expanding diagnostic infrastructure and a large patient population seeking targeted therapeutic solutions. Asia Pacific's theranostics market growth is supported by technological advancements in imaging and molecular diagnostics.
  • Key markets within Asia Pacific, including China, Japan, and India, are accelerating theranostics adoption through government initiatives and private sector innovation.
  • Asia Pacific's competitive landscape reflects both established multinational players and emerging regional companies capitalizing on the region's healthcare modernization trends..

Key Market Statistics

  • CAGR (2023-2028) 13.8% CAGR
  • Market Size, 2023 ~USD 565.1 Million
  • Forecast, 2028 ~USD 1077.5 Million
  • Geography Asia Pacific

Asia Pacific Theranostics Market Overview

Market Valuation & Growth :

Asia Pacific theranostics market valued at $565.1 million in 2023, expanding at 13.8% CAGR to reach $1,077.5 million by 2028, demonstrating strong regional momentum.

Healthcare Investment Surge :

Rising healthcare expenditures across Asia Pacific nations, particularly in China, Japan, and India, are accelerating theranostics adoption and infrastructure development.

Chronic Disease Prevalence :

Increasing burden of cancer, cardiovascular diseases, and diabetes in Asia Pacific populations is driving demand for integrated diagnostic and therapeutic solutions.

Precision Medicine Adoption :

Growing regional shift toward personalized treatment approaches and genomic medicine is positioning theranostics as a critical component of modern healthcare delivery.

Asia Pacific Theranostics Market Dynamics

  • Key markets including China, Japan, and India are investing heavily in precision medicine capabilities, creating favorable conditions for theranostics adoption.
  • Regulatory frameworks are gradually aligning with international standards, facilitating market entry and product innovation. Regional healthcare providers are increasingly recognizing theranostics' value in improving patient outcomes and reducing treatment costs.
  • Government initiatives supporting diagnostic advancement, coupled with growing patient awareness, will further accelerate market penetration.
  • The convergence of technological innovation, healthcare investment, and disease prevalence positions Asia Pacific as a high-growth theranostics market with significant long-term potential..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • SANOFI
  • Merck KGaA
  • NOVARTIS
  • Pfizer Inc.

    Key Takeaways

    • Asia Pacific theranostics market is projected to nearly double from $565.1M (2023) to $1,077.5M (2028), representing a 13.8% CAGR.
    • Asia Pacific's growth outpaces global trends through increased precision medicine adoption and diagnostic infrastructure expansion.
    • Asia Pacific markets including China, Japan, and India are primary growth engines driven by healthcare modernization and chronic disease prevalence.
    • Asia Pacific theranostics adoption is accelerated by government support, technological innovation, and rising patient demand for targeted treatments.

    Theranostics Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment THERANOSTICS CENTERS (End User)
    Forecast Period 2023-2028
    Growth Rate CAGR of 15.5% from 2023 to 2028
    Largest Segment RADIOPHARMACEUTICALS (Product)
    Market Size Base Year (Billions) ~USD 2.09 (2023)
    Revenue Forecast (Billions) ~USD 4.3 (2028)
    Segments Covered Product, Type, Application, End User

    Asia Pacific Theranostics Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Imaging
    • Ivd/Biomarker Screening
    • Radiopharmaceuticals
    • Software & Services

    By Type

    • Iodine-131
    • Lutetium-177
    • Other Radiopharmaceuticals
    • Radium-223
    • Samarium-153
    • Yttrium-90

    By Application

    • Bone Metastasis
    • Other Applications
    • Other Cancer
    • Other Cancers
    • Prostate Cancer

    By End User

    • Hospitals And Cancer Care Centers
    • Research And Academic Centers
    • Theranostics Centers

    Target Audience

    • Medical Device Manufacturers : Require Asia Pacific market data to develop region-specific theranostics products, identify growth opportunities, and establish manufacturing or distribution partnerships.
    • Pharmaceutical Companies : Need detailed market insights to align theranostic drug development with regional demand, regulatory pathways, and healthcare provider adoption patterns.
    • Healthcare Investors & PE Firms : Seek comprehensive market sizing and growth forecasts for Asia Pacific theranostics to evaluate investment opportunities and portfolio company valuations.
    • Diagnostic Laboratory Operators : Require market intelligence on theranostics adoption rates, reimbursement trends, and competitive dynamics to guide service expansion and technology investments.
    • Healthcare Policy & Government Bodies : Need market data to inform healthcare policy, regulatory frameworks, and funding decisions supporting precision medicine and theranostics infrastructure development.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 2462.8 Million · 15.6% wtd CAGR ·
    Europe
    ~USD 698 Million · 19.4% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 346.5 Million
    JapanUSD 273.4 Million
    IndiaUSD 52.5 Million
    Rest Of Asia PacificUSD 25.6 Million

    Country market size visualization

    China
    USD 346.5 Million
    Japan
    USD 273.4 Million
    India
    USD 52.5 Million
    Rest Of Asia Pacific
    USD 25.6 Million

    Reasons to Buy this Report

    • Regional Market Sizing : Detailed market valuation for Asia Pacific and country-level breakdowns including China ($346.5M), Japan ($273.4M), and India ($52.5M) to support investment decisions.
    • Growth Trajectory Analysis : Comprehensive CAGR projections (13.8%) through 2028 enabling accurate forecasting and strategic planning for market entry or expansion in high-growth Asia Pacific segments.
    • Competitive Landscape Intelligence : Insights into regional market dynamics, key players, and competitive positioning specific to Asia Pacific theranostics, differentiating from global market trends.
    • Healthcare Investment Trends : Analysis of rising healthcare expenditures and government initiatives across Asia Pacific nations driving theranostics adoption and infrastructure development.
    • Precision Medicine Adoption Drivers : Understanding of regional factors accelerating precision medicine adoption, chronic disease prevalence, and regulatory environment shaping theranostics market opportunities.

    Frequently asked questions

    What is the current size of the Asia Pacific theranostics market?

    The Asia Pacific theranostics market was valued at $565.1 million in 2023 and is expected to grow to $1,077.5 million by 2028.

    What is the projected CAGR for Asia Pacific theranostics?

    Asia Pacific theranostics market is expected to grow at a compound annual growth rate (CAGR) of 13.8% from 2023 to 2028.

    Which countries drive the Asia Pacific theranostics market?

    Key markets within Asia Pacific include China, Japan, and India, which are leading adoption through healthcare investments and precision medicine initiatives.

    What factors are driving growth in Asia Pacific theranostics?

    Asia Pacific theranostics growth is driven by rising healthcare investments, chronic disease prevalence, precision medicine adoption, and expanding diagnostic infrastructure.

    How does Asia Pacific theranostics growth compare to global trends?

    Asia Pacific's 13.8% CAGR demonstrates strong regional momentum, supported by healthcare modernization and large patient populations seeking targeted therapies.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the theranostics market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial theranostics market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as OEMs, CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the theranostics market. The primary sources from the demand side include medical CDMOs, oncologists, doctors, radiologists, technicians, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Theranostics Market Size, and Share

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Estimation Methodology

    In this report, the theranostics market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insigh ts gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

    Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

    • Generating a list of major global players operating in the theranostics market.
    • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
    • Revenue mapping of major players to cover a major share of the global market share, as of 2022
    • Extrapolating the global value of the theranostics market industry

    Theranostics Market Size, and Share

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global theranostics market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using top-down and bottom-up approaches.

    Market Definition

    Theranostics is a term used for diagnosis and therapy. Theranostics can be broadly defined as a combination of molecularly targeted imaging and therapy, whereas imaging helps to gain information regarding presence of targeted moleculaes on cell surface and therapy progression. Radiotheranostics involves the use of radionuclide/radiopharmaceutical that delivers targeted radiation to kill the cancerous cells and imaging modality such as positron emission tomography (PET) is used to locate the cancer.  FDA approved theranostics procedures are performed for different applications such as prostate cancer, neuroendocrine tumor, etc. These procedures are mainly performed in hospitals, cancer care centers, and  theranostics centers.

    Key Stakeholders

    • Senior Management
    • End Users
    • R&D Department
    • Finance/Procurement Department

    Objectives of the Study

    • To define, describe, and forecast the size of theranostics market based on product, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)  
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market.   
    • To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to three major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and Rest of the World (Latin America and Middle East and Africa).
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
    • To track and analyze the competitive developments undertaken in the global market, such as product launches; agreements; expansions; and mergers & acquisitions.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global theranostics market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top fifteen companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographic Analysis

    • Further breakdown of the Rest of Europe theranostics market into Italy, Spain Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific theranostics market into Australia, South Korea, Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries

    Get the Full Theranostics Market Report

    Full forecast, segment splits, and company analysis for all Theranostics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status